Stock Signal
powered by ChatGPT
Sign in
Biotech News - Stock Signal | Stock Signal
Nov 14, 6:18 AM
Merck seen nearing acquisition of Cidara Therapeutics in deal potentially above $3.3 billion
CDTX
MRK
Nov 14, 5:36 AM
Fennec Pharmaceuticals plans share offering in Canada to raise up to $5 million
FENC
Nov 14, 2:42 AM
GeoVax outlines expedited GEO-MVA clinical trial and global partnership strategy for 2025-2026
GOVX
Nov 14, 2:42 AM
Vaxart extends cash runway into Q2 2027 with Dynavax partnership and targets 2026 data readouts
VXRT
Nov 14, 1:22 AM
Trevi Therapeutics targets multiple phase III trial launches for chronic cough indications in 2026 as regulatory plans accelerate
TRVI
Nov 14, 1:22 AM
Aytu BioPharma outlines $10M EXXUA launch investment and targets breakeven at $17.3M quarterly revenue as ADHD franchise holds strong
AYTU
Nov 14, 1:02 AM
Tela Bio outlines at least 16% 2025 revenue growth target while strengthening commercial team and balance sheet
TELA
Nov 14, 12:52 AM
Cibus outlines $200M annual rice royalty target while advancing global commercialization strategy
CBUS
Nov 14, 12:22 AM
Owlet raises 2025 revenue guidance to $103M-$106M while expanding global Dream Sock adoption
OWLT
OWLTW
Nov 13, 11:42 PM
Strata Skin Sciences outlines threefold market expansion opportunity as CPT code revisions approach 2027
SSKN
